Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chiemi Obata"'
Autor:
Yoshihisa, Ishiura, Yasutaka, Shiba, Hideko, Ikeda, Yasushi, Terasaki, Yoshinobu, Hinoue, Youichi, Ishida, Hideko, Hayase, Kazumi, Maruyama, Mayumi, Hamada, Chiemi, Obata, Mika, Ishikawa, Kazunori, Hirokami, Kazuo, Kasahara, Masaki, Fujimura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 41(6)
Increasing number of patients with advanced non-small cell lung cancer are receiving outpatient maintenance chemotherapy. It is very important to maintain these patients' quality of life(QOL). Pemetrexed has been reported to be an effective maintenan
Autor:
Yoshihisa, Ishiura, Hiroki, Yamamoto, Yasutaka, Shiba, Yasushi, Terasaki, Youichi, Ishida, Fumiko, Tanikawa, Hideko, Hayase, Kazumi, Maruyama, Chiemi, Obata, Mika, Ishikawa, Kazunori, Hirokami, Kazuo, Kasahara, Masaki, Fujimura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 40(7)
An increasing number of patients with lung cancer are undergoing outpatient chemotherapy. It is very important to maintain good quality of life(QOL)for these patients, and Japanese traditional medicine, TJ-41, has been reported to improve the QOL of
Autor:
Yoshihisa, Ishiura, Hiroki, Yamamoto, Yasushi, Terasaki, Youichi, Ishida, Wataru, Fukushima, Hisashi, Hirosawa, Ryouhei, Izumi, Fumiko, Tanikawa, Hideko, Hayase, Kazumi, Maruyama, Chiemi, Obata, Mika, Ishikawa, Kazuo, Kasahara, Masaki, Fujimura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(13)
An increasing number of patients with lung cancer are undergoing outpatient chemotherapy as an alternative to inpatient therapy. To investigate the factors influencing the quality of life (QOL) for these patients, we administered a QOL questionnaire,
Autor:
Kazuo Kasahara, Norikazu Hirokami, Yoshihisa Ishiura, Mayumi Hamada, Yasutaka Shiba, Kazumi Maruyama, Chiemi Obata, Hideko Hayase, Hideko Ikeda
Publikováno v:
Annals of Oncology. 25:v101
A 48-year-old woman was admitted to our hospital for 7-th line chemotherapy. Repeated treatment with carboplatin (AUC 6, day 1), nab-paclitaxel (100 mg/m2, day 1, 8, 15) were effective in this patient. Chmotherapy with nab-paclitaxel may be effective
Autor:
Kazuo Kasahara, Yoshihisa Ishiura, Hideko Ikeda, W. Fukushima, Yasutaka Shiba, F. Tanikawa, Chiemi Obata, Norikazu Hirokami, Hideko Hayase, Y. Tearasaki
Publikováno v:
Annals of Oncology. 24:ix90